Abstract
To explore the more active antitumor compounds, two series of new xanthones, containing 1,4-disubstituted-1,2,3-triazole moiety were designed and synthesized. Eaton’s Reagent and “click reaction” were used in the synthesis. Most of the title compounds showed good inhibitory activity against the hepatoma carcinoma cell line (Bel-7402) and human cervical carcinoma cell line (HeLa) in vitro. Compounds 10a, 10e, 10f, 11r and 11t had potent activity with IC50 values, ranging from 2.2 ± 0.17 to 7.1 ± 0.27 ∝M, which was equivalent to Doxorubicin.
This is a preview of subscription content, log in via an institution to check access.
References
Abdel-Lateff, A., Klemke, C., Konig, G. M., and Wright, A. D., Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus. J. Nat. Prod., 66, 706–708 (2003).
Chung, M. I., Weng, J. R., Wang, J. P., Teng, C. M., and Lin, C. N., Antiplatelet and anti-inflammatory constituents and new oxygenated xanthones from Hypericum geminiflorum. Planta Med., 68, 25–29 (2002).
Eaton, P. E., Carlson, G. R., and Lee, J. T., Phosphorus pentoxide-methanesulfonic acid. Convenient alternative to polyphosphoric acid. J. Org. Chem., 38, 4071–4073 (1973).
El Akri, K., Bougrin, K., Balzarini, J., Faraj, A., and Benhida, R., Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides. Bioorg. Med. Chem. Lett., 17, 6656–6659 (2007).
Fernandes, E. R., Carvalho, F. D., Remiao, F. G., Bastos, M. L., Pinto, M. M., and Gottlieb, O. R., Hepatoprotective activity of xanthones and xanthonolignoids against tert-butylhydroperoxide-induced toxicity in isolated rat hepatocytes-comparison with silybin. Pharm. Res., 12, 1756–1760 (1995).
Hu, H., Liao, H., Zhang, J., Wu, W., Yan, J., Yan, Y., Zhao, Q., Zou, Y., Chai, X., Yu, S., and Wu, Q., First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. Bioorg. Med. Chem. Lett., 20, 3094–3097 (2010).
Kamal, A., Shankaraiah, N., Devaiah, V., Laxma Reddy, K., Juvekar, A., Sen, S., Kurian, N., and Zingde, S., Synthesis of 1,2,3-triazole-linked pyrrolobenzodiazepine conjugates employing ‘click’ chemistry: DNA-binding affinity and anticancer activity. Bioorg. Med. Chem. Lett., 18, 1468–1473 (2008).
Kostakis, I. K., Pouli, N., Marakos, P., Kousidou, O., Roussidis, A., Tzanakakis, G. N., and Karamanos, N. K., Design, synthesis and cell growth inhibitory activity of a series of novel aminosubstituted xantheno[1,2-d]imidazoles in breast cancer cells. Bioorg. Med. Chem., 16, 3445–3455 (2008).
Mahabusarakam, W., Proudfoot, J., Taylor, W., and Croft, K., Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic. Res., 33, 643–659 (2000).
Malnuit, V., Duca, M., Manout, A., Bougrin, K., and Benhida, R., Tandem azide-alkyne 1,3-dipolar cycloaddition/electrophilic addition: a concise three-component route to 4,5-disubstituted triazolyl-nucleosides. Synlett, 2009, 2123–2126 (2009).
Moody, T. W., Chiles, J., Moody, E., Sieczkiewicz, G. J., and Kohn, E. C., CAI inhibits the growth of small cell lung cancer cells. Lung Cancer, 39, 279–288 (2003).
Park, K. H., Park, Y. D., Han, J. M., Im, K. R., Lee, B. W., Jeong, I. Y., Jeong, T. S., and Lee, W. S., Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata. Bioorg. Med. Chem. Lett., 16, 5580–5583 (2006).
Pautus, S., Yee, S. W., Jayne, M., Coogan, M. P., and Simons, C., Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles. Bioorg. Med. Chem., 14, 3643–3653 (2006).
Peres, V., Nagem, T. J., and De Oliveira, F. F., Tetraoxygenated naturally occurring xanthones. Phytochemistry, 55, 683–710 (2000).
Pinto, M. M., Sousa, M. E., and Nascimento, M. S., Xanthone derivatives: new insights in biological activities. Curr. Med. Chem., 12, 2517–2538 (2005).
Rivera, D. G., Balmaseda, I. H., Leon, A. A., Hernandez, B. C., Montiel, L. M., Garrido, G. G., Cuzzocrea, S., and Hernandez, R. D., Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin. J. Pharm. Pharmacol., 58, 385–392 (2006).
Tanaka, N., Kashiwada, Y., Kim, S.-Y., Sekiya, M., Ikeshiro, Y., and Takaishi, Y., Xanthones from Hypericum chinense and their cytotoxicity evaluation. Phytochemistry, 70, 1456–1461 (2009).
Vieira, L. M. and Kijjoa, A., Naturally-occurring xanthones: recent developments. Curr. Med. Chem., 12, 2413–2446 (2005).
Woo, S., Jung, J., Lee, C., Kwon, Y., and Na, Y., Synthesis of new xanthone analogues and their biological activity test—Cytotoxicity, topoisomerase II inhibition, and DNA crosslinking study. Bioorg. Med. Chem. Lett., 17, 1163–1166 (2007).
Zeytinoglu, H., Incesu, Z., and Baser, K. H., Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. Phytomedicine, 10, 292–299 (2003).
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zou, Y., Zhao, Q., Hu, H. et al. Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety. Arch. Pharm. Res. 35, 2093–2104 (2012). https://doi.org/10.1007/s12272-012-1206-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-1206-4